BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 26509555)

  • 21. Transient elastography for the prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetes: Evidence from the CORDIAL cohort study.
    Alfadda AA; Sherbeeni SM; Alqutub AN; Aldosary AS; Aldaghri NM; Taylor-Robinson SD; Alqahtani SA; Gul R; Almaghamsi AM
    Saudi J Gastroenterol; 2022; 28(6):426-433. PubMed ID: 35645140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography - a prospective, cross sectional study.
    Mikolasevic I; Domislovic V; Turk Wensveen T; Delija B; Klapan M; Juric T; Lukic A; Mijic A; Skenderevic N; Puz P; Ostojic A; Krznaric Z; Radic-Kristo D; Filipec Kanizaj T; Stimac D
    Eur J Intern Med; 2020 Dec; 82():68-75. PubMed ID: 32839076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased aortic stiffness predicts future development and progression of peripheral neuropathy in patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CR; Moran CB; Marinho FS; Ferreira MT; Salles GF
    Diabetologia; 2015 Sep; 58(9):2161-8. PubMed ID: 26044207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. When the liver gets stiff, the tough get moving.
    Nguyen TH; Wardell R; Chitturi S; Teoh N; Farrell G
    J Gastroenterol Hepatol; 2020 Jun; 35(6):953-959. PubMed ID: 31867782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes.
    Sobhonslidsuk A; Pulsombat A; Kaewdoung P; Petraksa S
    Asian Pac J Cancer Prev; 2015; 16(5):1789-94. PubMed ID: 25773826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver fibrosis by FibroScan
    Lombardi R; Airaghi L; Targher G; Serviddio G; Maffi G; Mantovani A; Maffeis C; Colecchia A; Villani R; Rinaldi L; Orsi E; Pisano G; Adinolfi LE; Fargion S; Fracanzani AL
    Liver Int; 2020 Feb; 40(2):347-354. PubMed ID: 31612634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy.
    Cassinotto C; Boursier J; de Lédinghen V; Lebigot J; Lapuyade B; Cales P; Hiriart JB; Michalak S; Bail BL; Cartier V; Mouries A; Oberti F; Fouchard-Hubert I; Vergniol J; Aubé C
    Hepatology; 2016 Jun; 63(6):1817-27. PubMed ID: 26659452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholic fatty liver disease: An Italian community-based population study.
    Conti F; Vukotic R; Foschi FG; Domenicali M; Giacomoni P; Savini S; Lanzi A; Dall'Aglio AC; Saini G; Matroroberto M; Bernardi M; Stefanini GF; Andreone P
    Dig Liver Dis; 2016 Nov; 48(11):1357-1363. PubMed ID: 27522549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aortic-Brachial Pulse Wave Velocity Ratio: A Blood Pressure-Independent Index of Vascular Aging.
    Fortier C; Sidibé A; Desjardins MP; Marquis K; De Serres SA; Mac-Way F; Agharazii M
    Hypertension; 2017 Jan; 69(1):96-101. PubMed ID: 27821616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Aortic Stiffness and Pressure Pulsatility With Noninvasive Estimates of Hepatic Steatosis and Fibrosis: The Framingham Heart Study.
    Cooper LL; Prescott BR; Xanthakis V; Benjamin EJ; Vasan RS; Hamburg NM; Long MT; Mitchell GF
    Arterioscler Thromb Vasc Biol; 2024 Jul; 44(7):1704-1715. PubMed ID: 38752348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The presence of diabetes impacts liver fibrosis and steatosis by transient elastography in a primary care population.
    Trivedi HD; Suri J; Oh D; Schwartz J; Goyes D; Idriss R; Curry MP; Lai M
    Ann Hepatol; 2021; 24():100336. PubMed ID: 33647502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severity of coronary artery disease is associated with non-alcoholic fatty liver dis-ease: A single-blinded prospective mono-center study.
    Friedrich-Rust M; Schoelzel F; Maier S; Seeger F; Rey J; Fichtlscherer S; Herrmann E; Zeuzem S; Bojunga J
    PLoS One; 2017; 12(10):e0186720. PubMed ID: 29073252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel 2-step approach combining the NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis.
    Chan WK; Nik Mustapha NR; Mahadeva S
    Hepatol Int; 2015 Oct; 9(4):594-602. PubMed ID: 25788185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe.
    Myers RP; Pomier-Layrargues G; Kirsch R; Pollett A; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
    J Hepatol; 2012 Mar; 56(3):564-70. PubMed ID: 22027584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE.
    Doycheva I; Cui J; Nguyen P; Costa EA; Hooker J; Hofflich H; Bettencourt R; Brouha S; Sirlin CB; Loomba R
    Aliment Pharmacol Ther; 2016 Jan; 43(1):83-95. PubMed ID: 26369383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. US Time-Harmonic Elastography: Detection of Liver Fibrosis in Adolescents with Extreme Obesity with Nonalcoholic Fatty Liver Disease.
    Hudert CA; Tzschätzsch H; Guo J; Rudolph B; Bläker H; Loddenkemper C; Luck W; Müller HP; Baumgart DC; Hamm B; Braun J; Holzhütter HG; Wiegand S; Sack I
    Radiology; 2018 Jul; 288(1):99-106. PubMed ID: 29762096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transient Elastography Is the Best-Performing Non-Invasive Test of Liver Fibrosis in Obese Asian Patients with Non-Alcoholic Fatty Liver Disease: A Pilot, Cross-Sectional Study.
    Kalaiyarasi K; Sanchalika A; Hsien Min L; Wei Ming Y; Vishalkumar S; Kuo Chao Y; Jee Keem L; Sameer J; Terence HCW; Yen Ping T
    Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38256429
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver Disease.
    Ajmera VH; Liu A; Singh S; Yachoa G; Ramey M; Bhargava M; Zamani A; Lopez S; Mangla N; Bettencourt R; Rizo E; Valasek M; Behling C; Richards L; Sirlin C; Loomba R
    Hepatology; 2020 Mar; 71(3):849-860. PubMed ID: 31556124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased Arterial Stiffness is an Independent Predictor of Renal Function Decline in Patients With Type 2 Diabetes Mellitus Younger Than 60 Years.
    Fountoulakis N; Thakrar C; Patel K; Viberti G; Gnudi L; Karalliedde J
    J Am Heart Assoc; 2017 Mar; 6(4):. PubMed ID: 28360227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of non-alcoholic fatty liver disease (NAFLD) in a cohort of patients with type 2 diabetes: the PHIGNA-DM2 study.
    Martínez-Ortega AJ; Piñar Gutiérrez A; Lara-Romero C; Remón Ruiz PJ; Ampuero-Herrojo J; de Lara-Rodríguez I; Romero-Gómez M; García Luna PP; Soto-Moreno A
    Nutr Hosp; 2022 Oct; 39(5):1012-1018. PubMed ID: 36134588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.